PHARMACOKINETIC MODEL FOR DIAZEPAM AND ITS MAJOR METABOLITE DESMETHYLDIAZEPAM FOLLOWING DIAZEPAM ADMINISTRATION

被引：21

作者：

JACK, ML ^{[1
]}

COLBURN, WA ^{[1
]}

机构：

[1] HOFFMANN LA ROCHE INC,DEPT PHARMACOKINET & BIOPHARMACEUT,NUTLEY,NJ 07110

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 1983年 / 72卷 / 11期

关键词：

D O I：

10.1002/jps.2600721120

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1318 / 1323

页数：6

共 24 条

[1] CHANGES IN ORAL ABSORPTION CHARACTERISTICS IN MAN OF DIPOTASSIUM CLORAZEPATE AT NORMAL AND ELEVATED GASTRIC PH [J].

ABRUZZO, CW ;

MACASIEB, T ;

WEINFELD, R ;

RIDER, JA ;

KAPLAN, SA .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1977, 5 (04) :377-390

[2] COMPARATIVE PROTEIN-BINDING OF DIAZEPAM AND DESMETHYLDIAZEPAM [J].

ALLEN, MD ;

GREENBLATT, DJ .

JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 20 (11-1) :639-643

[3] CONTROLLED-STUDY OF DIAZEPAM IN PSYCHIATRIC OUTPATIENTS [J].

BEERMAN, HM .

AMERICAN JOURNAL OF PSYCHIATRY, 1964, 120 (09) :870-&

[4] DETERMINATION OF CHLORAZEPATE AND ITS MAJOR METABOLITES IN BLOOD AND URINE BY ELECTRON-CAPTURE GAS-LIQUID-CHROMATOGRAPHY [J].

BROOKS, MA ;

HACKMAN, MR ;

WEINFELD, RE ;

MACASIEB, T .

JOURNAL OF CHROMATOGRAPHY, 1977, 135 (01) :123-131

[5] STEADY-STATE BIOAVAILABILITY OF 2 CLORAZEPATE DIPOTASSIUM DOSAGE FORMS [J].

CARRIGAN, PJ ;

CHAO, GC ;

BARKER, WM ;

HOFFMAN, DJ ;

CHUN, AHC .

JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 17 (01) :18-28

[6]

CHUN AHC, 1977, CLIN PHARMACOL THER, V22, P329

[7]

COTLER S, J PHARM SCI

[8] EFFECTS AND PLASMA-LEVELS OF N-DESMETHYLDIAZEPAM AFTER ORAL-ADMINISTRATION IN NORMAL VOLUNTEERS [J].

DASBERG, HH .

PSYCHOPHARMACOLOGIA, 1975, 43 (02) :191-198

[9]

De Silva J A, 1970, Anal Chem, V42, P1725, DOI 10.1021/ac50160a040

[10] DIAZEPAM, A NEW TRANQUILIZER [J].

DIFRANCESCO, A .

AMERICAN JOURNAL OF PSYCHIATRY, 1963, 119 (10) :989-&

← 1 2 3 →